ISU
Home
ISURF/OIPTT
Home
ISURFtech
Home
Advanced
Search
RSS
Feeds
Hybridoma Cell Lines for the Production of Monoclonal Antibodies Against Mycoplasma Hyopneumonia
Category(s):
For Information, Contact:
Dario Valenzuela
Senior Commercialization Manager, Life Sciences
515-294-4740
licensing@iastate.edu
Web Published:
5/22/2015
ISURF #
2050
Development Stage:
Description:
Hybridoma cell lines F1B6 and F2G5 produce monoclonal antibodies which are unique in their ability to inhibit the in vitro adherence of M. hyopneumoniae to swine cilia. The tracheal cilia are the natural targets to which the mycoplasma binds during in vivo infection. The antibodies are important in the characterization of M. hyopneumoniae isolates by immunoblotting and adherence inhibition, and in purification of M. hyopneumoniae adhesins
Application:
- Veterinary diagnostics
- Vaccine quality control
The cell lines are available for non-exclusive licensing.
Patent Information:
*To see the full version of the patent(s), follow the link below, then click on "Images" button.

Intellectual Property:
Tangible material


Direct Link: